Factor IX Deficiency

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Swedish Orphan Biovitrum
1 program
Standard care with blood and urine sample collectionN/A1 trial
Active Trials
NCT02502409UnknownEst. Dec 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Swedish Orphan BiovitrumStandard care with blood and urine sample collection

Clinical Trials (1)

NCT02502409Swedish Orphan BiovitrumStandard care with blood and urine sample collection

Natural History Study of Factor IX Treatment and Complications

Start: Jul 2015Est. completion: Dec 2021
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space